Souhami 1991.

Methods	RCT 1984‐1986
Participants	103 (4*) FIGO stage IIIB patients
Interventions	CT + RT vs RT CT: CDDP 50mg/m2 BLM 120U VCR 1mg/m2 MMC 10mg/m2. Every 21 days for 3 cycles. RT: 50Gy in 25F over 35 days. Intracavitary 40Gy
Outcomes	Survival Disease‐free survival Loco‐regional diease‐free survival Metastases‐free survival Late toxicity
Notes	Treatment comparison 1
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ Adequate